Not provided
| ID | Type | Description | Link |
|---|---|---|---|
| 2016-A00754-47 | Other Identifier | ID-RCB |
Not provided
Not provided
No participant enrolled
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Considering the frequent occurence of peri-implantitis and mucositis, a multiple of treatment alternatives have been proposed including non-surgical and surgical procedures. However, it seems that the most effective treatment remains prevention of these diseases.
The aim of this study is to emphasize on mucositis and peri-implantitis prevention using an air abrasion device the Air-Flow Master Piezon® with erythritol and chlorhexidine powder in order to eliminate and / or disorganize the biofilm responsible for peri-implant mucosa inflammation.
Peri-implant infections (mucositis and peri-implantitis) depict an increasing focus in dental practice and implantology. mean prevalence of mucositis is of 43% and periimplantitis of 22%. Consequences for the implant without successful treatment range from local reversible inflammation (mucositis) to implant loss (periimplantitis). These lead to functional, social and esthetic prejudices for patients. The main factor for establishment of peri-implant infections is the formation and maturation of the bacterial biofilm. Peri-implantitis and mucositis treatment require the removal of the bacterial biofilm and the disinfection of the implant surface. Because of special surface conditions and structures, it is more difficult to remove bacterial biofilms from implant surfaces than teeth. the key to controlling the inflammation due to the bacterial biofilm is to prevent its installation and progression. The procedure tested in this study is an air abrasion device, the Air-Flow Master Piezon® with erythritol and chlorhexidine powders on implants presenting clinical and radiographic signs of mucositis and peri-implantitis along with renewal of local oral hygiene instructions in order to reduce the inflammation locally by disorganizing and eliminating the biofilm. Follow-up of the patients will be held every 2 months for 6 months by scoring the bleeding on probing, the plaque index and measuring clinical attachment level in order to compare it with the initial measure. At 6 month an X-ray will also enable to compare bone level and mineralization. This initial study will help establish a standardized protocol for peri-implant infection management.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Air-polishing device | Experimental | Air polishing of the implant surface and/or elimination of the intrapocket biofilm using the air abrasion device Air-Flow Master Piezon® |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Air-polishing device | Device | Air abrasion using the Air-Flow Master Piezon® with erythritol and Chlorhexidine powders on implants presenting clinical and radiographic signs of mucositis and peri-implantitis along with renewal of local oral hygiene instructions in order to reduce the inflammation locally |
| Measure | Description | Time Frame |
|---|---|---|
| Change from baseline peri-implant inflammation at 6 months | bleeding on probing (binary criteria : yes/no) | 6 months |
| Change from baseline peri-implant inflammation at 4 months | bleeding on probing (binary criteria : yes/no) | 4 months |
| Change from baseline peri-implant inflammation at 2 months | bleeding on probing (binary criteria : yes/no) | 2 months |
| Measure | Description | Time Frame |
|---|---|---|
| stability of the bone level | bone level assessed by X-ray | 6 months |
| clinical attachment gain | The measurement of the probing depth and of the eventual recession (compared to Baseline) allows to assess the clinical attachment gain |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Sara Laurencin, MD | University Hospital of Toulouse | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| University Hospital Toulouse (Faculty of Dental Surgery) | Toulouse | 31059 | France |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D057873 | Peri-Implantitis |
| D052016 | Mucositis |
| ID | Term |
|---|---|
| D010510 | Periodontal Diseases |
| D009059 | Mouth Diseases |
| D009057 | Stomatognathic Diseases |
| D005759 | Gastroenteritis |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
|
|
| 2 months |
| clinical attachment gain | The measurement of the probing depth and of the eventual recession (compared to Baseline) allows to assess the clinical attachment gain | 4 months |
| clinical attachment gain | The measurement of the probing depth and of the eventual recession (compared to Baseline) allows to assess the clinical attachment gain | 6 months |
| Quality of life with Oral Health Assessment Tool (OHAT) | The Oral Health Assessment Tool (OHAT) was a component of the Best Practice Oral Health Model for Australian Residential Care study. The OHAT provided institutional carers with a simple, eight category screening tool to assess residents' oral health, including those with dementia | 6 months |
| Quality of life with the Geriatric Oral Health Assessment Index (GOHAI) | The Geriatric Oral Health Assessment Index (GOHAI) is a self-reported measure designed to assess the oral health problems of older adults | 6 months |
| D005767 |
| Gastrointestinal Diseases |
| D004066 | Digestive System Diseases |